TNL Mediagene (TNMG)

TNL Mediagene Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	48.49	35.84	20.01
Revenue Growth (YoY)	35.31%	79.10%	-
Cost of Revenue	30.76	23.19	12.27
Gross Profit	17.74	12.65	7.74
Selling, General & Admin	62	16.42	8.65
Research & Development	3.05	3.33	2.51
Operating Expenses	65.06	19.75	11.16
Operating Income	-47.32	-7.1	-3.42
Interest Expense	-0.39	-0.29	-0.14
Interest & Investment Income	0.02	0.02	0.01
Currency Exchange Gain (Loss)	-0.16	-0.01	-0.12
Other Non Operating Income (Expenses)	-8.41	5.87	-7.98
EBT Excluding Unusual Items	-56.26	-1.51	-11.64
Gain (Loss) on Sale of Assets	0	0	0
Asset Writedown	-29.03	-0.3	-
Pretax Income	-85.28	-1.81	-11.64
Income Tax Expense	-0.31	-0.59	-0.25
Earnings From Continuing Operations	-84.98	-1.22	-11.39
Minority Interest in Earnings	-0.03	0.41	0.38
Net Income	-85	-0.8	-11.01
Net Income to Common	-85	-0.8	-11.01
Shares Outstanding (Basic)	25	18	9
Shares Outstanding (Diluted)	25	18	9
Shares Change (YoY)	33.29%	99.87%	-
EPS (Basic)	-3.46	-0.04	-1.20
EPS (Diluted)	-3.46	-0.04	-1.20
Free Cash Flow	-10.3	-1.51	-0.81
Free Cash Flow Per Share	-0.42	-0.08	-0.09
Gross Margin	36.58%	35.30%	38.69%
Operating Margin	-97.58%	-19.80%	-17.08%
Profit Margin	-175.29%	-2.25%	-55.04%
Free Cash Flow Margin	-21.24%	-4.22%	-4.06%
EBITDA	-45.31	-5.37	-2.4
EBITDA Margin	-93.44%	-14.99%	-12.00%
D&A For EBITDA	2	1.73	1.02
EBIT	-47.32	-7.1	-3.42
EBIT Margin	-97.58%	-19.80%	-17.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q